Researchers at The University of Queensland have developed a technique which aims to derive MSCs from Induced Pluripotent Stem Cells (iPSC) through a two step procedure. The potentially automated procedure would not require manual work to produce the cells, which means that iPSCs could be differentiated on a large scale suitable for industrial use, reducing cost and increasing quality controls.

This technology allows the mass production of cells which may be used in a number of these applications, including growth or new muscle, bone or cartilage in vivo or ex vivo.

• Licenceⁱ